Trial · NCT00572455
Participant flow98
How many started, completed or left each group, period by period.
1 to 20 of 98
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage I (14 Days) | STARTED | Taprenepag 0.0025% (Stage I) | 9 | |
| Stage I (14 Days) | STARTED | Taprenepag 0.005% (Stage I) | 9 | |
| Stage I (14 Days) | STARTED | Taprenepag 0.01% (Stage I) | 9 | |
| Stage I (14 Days) | STARTED | Taprenepag 0.015% (Stage I) | 10 | |
| Stage I (14 Days) | STARTED | Taprenepag 0.02% (Stage I) | 9 | |
| Stage I (14 Days) | STARTED | Taprenepag 0.03% (Stage I) | 9 | |
| Stage I (14 Days) | STARTED | Taprenepag Vehicle (Stage I) | 12 | |
| Stage I (14 Days) | STARTED | Latanoprost Vehicle and Taprenepag 0.005% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost Vehicle and Taprenepag 0.01% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost Vehicle and Taprenepag 0.015% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost 0.005% and Taprenepag 0.005% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost 0.005% and Taprenepag 0.01% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost 0.005% and Taprenepag 0.015% (Stage II) | 0 | |
| Stage I (14 Days) | STARTED | Latanoprost 0.005% and Taprenepag Vehicle (Stage II) | 0 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.0025% (Stage I) | 9 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.005% (Stage I) | 9 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.01% (Stage I) | 9 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.015% (Stage I) | 10 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.02% (Stage I) | 8 | |
| Stage I (14 Days) | COMPLETED | Taprenepag 0.03% (Stage I) | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00572455/flow